AVITA Medical, Inc. (RCEL): Capital Expenditures

Annual figures by period end, from SEC filings.

$1.00M
Year ended 2025-12-31
$387.0K
Trailing 12 months to 2026-06-30
+30.5%
3-year compound annual growth
$9.17M2018-06-30: $365.0K2019-06-30: $1.02M2020-06-30: $590.0K2021-06-30: $894.0K2022-12-31: $452.0K2023-12-31: $1.38M2024-12-31: $9.17M2025-12-31: $1.00M$1.00M
2018-06-30 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$1.00M-89.0%2026-02-12, From 2025-01-01
2024-12-31$9.17M+564.1%2026-02-12, From 2024-01-01
2023-12-31$1.38M+205.5%2025-02-13, From 2023-01-01
2022-12-31$452.0Kn/a2024-02-22, From 2022-01-01
No annual figure between 2021-06-30 and 2022-12-31.
2021-06-30$894.0K+51.5%2023-02-23, From 2020-07-01
2020-06-30$590.0K-42.2%2021-08-26, From 2019-07-01
2019-06-30$1.02M+179.7%2021-08-26, From 2018-07-01
2018-06-30$365.0Kn/a2020-08-27, From 2017-07-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
AVITA Medical, Inc. (RCEL)2025-12-31$1.00M-89.0%
Sight Sciences, Inc. (SGHT)2025-12-31$224.0K-41.8%
PRO DEX Inc (PDEX)2026-06-30$483.0K-61.2%
TELA Bio, Inc. (TELA)2025-12-31$448.0K-54.7%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$15.6K-88.3%
Iradimed Corp (IRMD)2025-12-31$7.76M-3.0%
Delcath Systems, Inc. (DCTH)2025-12-31$1.55M+176.7%
LENSAR, Inc. (LNSR)2025-12-31$83.0K-46.8%
Pulmonx Corp (LUNG)2025-12-31$452.0K-68.8%

Compare RCEL, SGHT, PDEX, TELA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗